Literature DB >> 10214733

Contrast-enhanced transcranial color-coded duplex sonography: efficiency and validity.

T Gerriets1, G Seidel, I Fiss, B Modrau, M Kaps.   

Abstract

OBJECTIVE: To evaluate the diagnostic efficiency and accuracy of contrast-enhanced transcranial color-coded sonography (CE-TCCS).
BACKGROUND: TCCS is hampered by insufficient ultrasonic penetration in 20% of cerebrovascular patients.
METHODS: In 47 patients whose basal arteries could not be assessed adequately, 59 TCCS examinations were performed before and after administration of the ultrasonic contrast agent (CA) Levovist. The assessability of different basal cerebral arteries after CA administration was evaluated off-line. Angiographic records were available from 11 patients.
RESULTS: Satisfactory investigation of the middle cerebral artery, the anterior cerebral artery, the P1 and P2 segments of the posterior cerebral artery, and the supraclinoid portion of the internal carotid artery siphon was possible in 5.1%, 28.8%, 35.6%, 55.9%, and 47.5% of patients before, and in 84.7%, 91.5%, 93.2%, 94.5%, and 93.2% of patients after contrast enhancement. Stenoses or occlusions of basal cerebral arteries were registered in 28 patients (60%). CE-TCCS diagnosis was confirmed by digital subtraction angiography or magnetic resonance angiography in 10 of the 11 patients, leading to positive and negative predictive values of 0.86 and 1.00.
CONCLUSION: Contrast enhancement improves the diagnostic potential of TCCS significantly in patients with temporal bone window failure, and proved to be a reliable method for detecting middle cerebral artery and siphon occlusion.

Entities:  

Mesh:

Year:  1999        PMID: 10214733     DOI: 10.1212/wnl.52.6.1133

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  8 in total

1.  Vertebrobasilar transcranial color-coded duplex ultrasonography: improvement with echo enhancement.

Authors:  Erwin Stolz; Martin Nückel; Irene Mendes; Tibo Gerriets; Manfred Kaps
Journal:  AJNR Am J Neuroradiol       Date:  2002 Jun-Jul       Impact factor: 3.825

2.  Echo-enhanced transcranial color-coded duplex sonography in the diagnosis of cerebrovascular events: a validation study.

Authors:  A Kunz; G Hahn; D Mucha; A Müller; K M Barrett; R von Kummer; G Gahn
Journal:  AJNR Am J Neuroradiol       Date:  2006 Nov-Dec       Impact factor: 3.825

Review 3.  The use of microbubbles in Doppler ultrasound studies.

Authors:  Piero Tortoli; Francesco Guidi; Riccardo Mori; Hendrik J Vos
Journal:  Med Biol Eng Comput       Date:  2008-11-11       Impact factor: 2.602

4.  Contrast-enhanced three-dimensional transcranial color-coded sonography of intracranial stenoses.

Authors:  Christof Klötzsch; Alessandro Bozzato; Gero Lammers; Michael Mull; Johannes Noth
Journal:  AJNR Am J Neuroradiol       Date:  2002-02       Impact factor: 3.825

5.  Diagnosis of middle cerebral artery occlusive lesions with contrast-enhanced transcranial color-coded real-time sonography in acute stroke.

Authors:  Toshiyasu Ogata; Kazumi Kimura; Makoto Nakajima; Hiroaki Naritomi; Kazuo Minematsu
Journal:  Neuroradiology       Date:  2005-03-24       Impact factor: 2.804

6.  Relationship between findings of conventional and contrast-enhanced transcranial color-coded real-time sonography and angiography in patients with basilar artery occlusion.

Authors:  Masatoshi Koga; Kazumi Kimura; Kazuo Minematsu; Takenori Yamaguchi
Journal:  AJNR Am J Neuroradiol       Date:  2002-04       Impact factor: 3.825

7.  Transcranial color-coded real-time sonographic criteria for occlusion of the middle cerebral artery in acute ischemic stroke.

Authors:  Toshiyasu Ogata; Kazumi Kimura; Makoto Nakajima; Kouichi Ikeno; Hiroaki Naritomi; Kazuo Minematsu
Journal:  AJNR Am J Neuroradiol       Date:  2004 Nov-Dec       Impact factor: 3.825

8.  Feasibility and validity of transcranial duplex sonography in patients with acute stroke.

Authors:  T Gerriets; M Goertler; E Stolz; T Postert; U Sliwka; F Schlachetzki; G Seidel; S Weber; M Kaps
Journal:  J Neurol Neurosurg Psychiatry       Date:  2002-07       Impact factor: 10.154

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.